Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Criticism of tumor response criteria raises trial design questions.

× No keyword cloud information.

6 in total

Review 1. Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.

Authors: Kyrre E Emblem; Christian T Farrar; Elizabeth R Gerstner; Tracy T Batchelor; Ronald J H Borra; Bruce R Rosen; A Gregory Sorensen; Rakesh K Jain
Journal: Nat Rev Clin Oncol Date: 2014-08-12 Impact factor: 66.675

Review 2. Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.

Authors: Hani J Alturkmani; Ziyan Y Pessetto; Andrew K Godwin
Journal: Expert Opin Investig Drugs Date: 2015-06-22 Impact factor: 6.206

Review 3. The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors.

Authors: Laura M Deford-Watts; Akiva Mintz; Steven J Kridel
Journal: Curr Pharm Biotechnol Date: 2013 Impact factor: 2.837

4. A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [(18)F]fluorothymidine-positron emission tomography.

Authors: Seung Jin Lee; Eun Jung Kim; Haeng Jung Lee; Seog Young Kim; Seung Jun Oh; Jin Sook Ryu; Dae Hyuk Moon; Jin-Hee Ahn; Sang-We Kim
Journal: Invest New Drugs Date: 2012-09-18 Impact factor: 3.850

5. Objective assessment of tumour response to therapy based on tumour growth kinetics.

Authors: E Mehrara; E Forssell-Aronsson; P Bernhardt
Journal: Br J Cancer Date: 2011-07-26 Impact factor: 7.640

6. Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

Authors: Mary Kathryn Abel; Michelle E Melisko; Hope S Rugo; A Jo Chien; Italia Diaz; Julia K Levine; Ann Griffin; Joseph McGuire; Laura J Esserman; Hala T Borno; Rita A Mukhtar
Journal: NPJ Breast Cancer Date: 2021-10-25

6 in total